Insulin Delivery Devices Market to 2019 - Simplified Pump Solutions and Low Cost Pens Represent Distinct Regional Growth Drivers

NEW YORK, April 14, 2014 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Insulin Delivery Devices Market to 2019 - Simplified Pump Solutions and Low Cost Pens Represent Distinct Regional Growth Drivers
http://www.reportlinker.com/p02077365/Insulin-Delivery-Devices-Market-to-2019---Simplified-Pump-Solutions-and-Low-Cost-Pens-Represent-Distinct-Regional-Growth-Drivers.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_Delivery_Technology

Insulin Delivery Devices Market to 2019 - Simplified Pump Solutions and Low Cost Pens Represent Distinct Regional Growth Drivers

Summary

GBI Research's report, 'Insulin Delivery Devices Market to 2019 - Simplified Pump Solutions and Low Cost Pens Represent Distinct Regional Growth Drivers' looks at the market, competitive landscape, and trends for the four insulin delivery devices market segments: insulin pens, insulin pumps, insulin syringes and traditional insulin pump accessories. It provides comprehensive information on the key trends affecting these segments, and key analytical content on the market dynamics.

The report also reviews the competitive landscape, analyzes each segment's pipeline products and gives details of important M&A deals. It is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GBI Research's team of industry experts.

Scope

- Key geographies: the US, Canada, the UK, Germany, France, Italy, Spain, Japan, China, India, Australia and Brazil.
- Information on market size for the four insulin delivery devices market segments: insulin pens, insulin pumps, insulin syringes and traditional insulin pump accessories.
- Annualized market revenue data forecast to 2019 and company share data for 2012.
- Qualitative analysis of key trends in the insulin delivery devices market.
- Information on the competitive landscape and the leading technologies of key players: Novo Nordisk A/S, Medtronic, Inc., Sanofi, Eli Lilly and Company, Becton, Dickinson and Company, Animas Corporation, Insulet Corporation, F. Hoffmann-La Roche Ltd., Abbott Laboratories.
- Information on reimbursement trends and market access for key countries.

Reasons to buy

- Develop business strategies by understanding the trends and developments driving the global insulin delivery devices market.
- Design and enhance your product development, marketing, and sales strategies.
- Exploit M&A opportunities by identifying the market players with the most innovative pipelines.
- Develop market-entry and market-expansion strategies.
- Identify the key players best positioned to take advantage of the emerging market opportunities.
- Exploit in-licensing and out-licensing opportunities by identifying the products most likely to ensure a robust return.
- Identify, understand and capitalize on the next big thing in the insulin delivery devices market landscape.
- Make more informed business decisions from insightful and in-depth analysis of the global insulin delivery devices market and the factors shaping it.
1 Table of Contents
1 Table of Contents 8
1.1 List of Tables 12
1.2 List of Figures 14
2 Introduction 16
3 Diabetes – Disease Overview 17
3.1 Types of Diabetes 17
3.1.1 Type 1 Diabetes 17
3.1.2 Type 2 Diabetes 17
3.1.3 Gestational Diabetes 17
3.1.4 Signs and Symptoms 17

3.1.5 Diabetes Diagnosis 18
4 Diabetes – Epidemiology 19
5 Global Insulin Delivery Devices Market: Device Overview 20
5.1 Insulin Pen 20
5.1.1 Reusable Pen 20
5.1.2 Disposable Pen 20
5.1.3 Pen Needle 20
5.2 Insulin Pump 21
5.2.1 Traditional Insulin Pump 21
5.2.2 Disposable Insulin Pump 21
5.3 Insulin Syringe 21
5.4 Traditional Insulin Pump Accessories 21
5.5 Comparison of Insulin Delivery Devices 21
6 Global Insulin Delivery Devices Market: Market Characterization 23
6.1 Global Insulin Delivery Devices Market, Revenue ($bn), 2005–2012 23
6.2 Global Insulin Delivery Devices Market, Revenue, 2012–2019 24
6.3 Insulin Delivery Devices Market, Global, Key Company Shares, 2012 25
6.3.1 Global 26
6.3.2 North America 26
6.3.3 Europe 27
6.3.4 Asia-Pacific 27

6.4 Insulin Delivery Devices Market, Key Trends 27
6.4.1 Companies Move Closer to Developing Fully Automated Artificial Pancreas System 28
6.4.2 Collaborations Foster Innovation in Insulin Delivery Devices Market 29
6.4.3 Inhaled Rapid-Acting Insulin Studied in Research of Artificial Pancreas System 30
6.5 Market Dynamics 31
6.5.1 Market Drivers 31
6.5.2 Market Restraints 37
7 Global Insulin Delivery Devices Market: Segment Analysis and Forecasts 39
7.1 Insulin Pens Market, Global, Revenue, 2005–2012 39
7.2 Insulin Pens Market, Global, Revenue, 2012–2019 40
7.3 Insulin Pumps Market, Global, Revenue, 2005–2012 41
7.4 Insulin Pumps Market, Global, Revenue, 2012–2019 42
7.5 Insulin Syringes Market, Global, Revenue, 2005–2012 43
7.6 Insulin Syringes Market, Global, Revenue, 2012–2019 44
7.7 Traditional Insulin Pump Accessories Market, Global, Revenue, 2005–2012 45
7.8 Traditional Insulin Pump Accessories Market, Global, Revenue, 2012–2019 46
8 Global Insulin Delivery Devices Market: Country Analysis and Forecasts 47
8.1 Insulin Delivery Devices Market: Cross-country Analysis 47
8.2 Historic and Forecast Revenue and Volume, by Country 48

8.2.1 Insulin Delivery Devices Market, US, Revenue and Volume, 2005–2019 48
8.2.2 Insulin Delivery Devices Market, Japan, Revenue and Volume, 2005–2019 51
8.2.3 Insulin Delivery Devices Market, Germany, Revenue and Volume, 2005–2019 53
8.2.4 Insulin Delivery Devices Market, France, Revenue, 2005–2012 56
8.2.5 Insulin Delivery Devices Market, UK, Revenue and Volume, 2005–2019 59
8.2.6 Insulin Delivery Devices Market, Spain, Revenue, Volume, 2005–2019 62
8.2.7 Insulin Delivery Devices Market, Italy, Revenue, Volume, 2005–2019 65
8.2.8 Insulin Delivery Devices Market, Canada, Revenue, Volume, 2005–2019 68
8.2.9 Insulin Delivery Devices Market, China, Revenue, Volume, 2005–2019 71
8.2.10 Insulin Delivery Devices Market, Australia, Revenue, Volume, 2005–2019 74
8.2.11 Insulin Delivery Devices Market, India, Revenue, 2005–2012 77
8.2.12 Insulin Delivery Devices Market, Brazil, Revenue, 2005–2019 80
9 Global Insulin Delivery Devices Market: Reimbursement System 84
9.1 US 84
9.2 Europe 84
9.2.1 Germany 84
9.2.2 France 84
9.2.3 Italy 84
9.2.4 Spain 84
9.2.5 UK 84
9.2.6 Denmark 84
9.2.7 Norway 85
9.2.8 Sweden 85
9.2.9 Belgium 85
9.2.10 Netherlands 85
9.2.11 Luxembourg 85
9.3 Asia-Pacific 85

10 Global Insulin Delivery Devices Market: Competitive Landscape 86
10.1 Comparison of Leading Insulin Pumps by Size and Color Options, 2014 86
10.2 Comparison of Leading Insulin Pumps by Basal and Bolus Specifications, 2014 87
10.3 Comparison of Leading Insulin Pumps by Bolus Calculator Options and Operation, 2014 88
10.4 Novo Nordisk (Subsidiary of Novo A/S) 88
10.4.1 Business Overview 88
10.4.2 Marketed Products 89
10.5 Sanofi 89
10.5.1 Business Overview 89
10.5.2 Marketed Products 89
10.6 Eli Lilly 89
10.6.1 Business Overview 89
10.6.2 Marketed Products 90
10.7 Medtronic 90
10.7.1 Business Overview 90
10.7.2 Marketed Products 90
10.8 Becton, Dickinson and Company 90
10.8.1 Business Overview 90
10.8.2 Marketed Products 91
10.9 Animas 91
10.9.1 Business Overview 91
10.9.2 Marketed Products 91
10.10 F. Hoffmann-La Roche 91
10.10.1 Business Overview 91
10.10.2 Marketed Products 92
10.11 Insulet 92
10.11.1 Business Overview 92

10.11.2 Marketed Products 92
10.12 Asante Solutions 92
10.12.1 Business Overview 92
10.13 Abbott Laboratories 93
10.13.1 Business Overview 93
10.13.2 Marketed Products 93
10.14 Ypsomed 93
10.14.1 Business Overview 93
10.14.2 Marketed Products 93
10.15 Owen Mumford 94
10.15.1 Business Overview 94
10.15.2 Marketed Products 94
10.16 Bioject Medical Technologies 94
10.16.1 Business Overview 94
10.16.2 Marketed Products 94
10.17 Injex - Equidyne Systems 95
10.17.1 Business Overview 95
10.17.2 Marketed Products 95
10.18 Antares Pharma 95
10.18.1 Business Overview 95
10.18.2 Marketed Products 95
10.19 Tandem Diabetes Care 96
10.19.1 Business Overview 96
10.19.2 Marketed Products 96
10.20 Tonghua Dongbao Pharmaceutical 96
10.20.1 Business Overview 96

10.20.2 Marketed Products 96
10.21 Shanghai Fosun Pharmaceutical 96
10.21.1 Business Overview 96
10.21.2 Marketed Products 97
11 Global Insulin Delivery Devices Market: Product Pipeline Analysis 98
11.1 Insulin Delivery Devices Market: List of Pipeline Products 99
11.1.1 Insulin Pumps, List of Pipeline Products 99
11.1.2 Insulin Pens, List of Pipeline Products 100
11.2 Insulin Delivery Devices Market: Profiles of Key Pipeline Products 100
11.2.1 5th Generation CGM Sensor with t:slim Insulin Delivery System 100
11.2.2 Accu-Chek Insight 100
11.2.3 Angel Touch 101
11.2.4 Animas Vibe Insulin Pump and CGM System 101
11.2.5 Bolus Patch 101
11.2.6 Cellnovo Wireless Insulin Pump System 102
11.2.7 Freehand Patch Pump 102
11.2.8 Insulin Pump 103
11.2.9 InsuPatch Device 103
11.2.10 Integrated CGM with Next Gen OmniPod System PDM 103
11.2.11 Jewel Pump 104
11.2.12 La Fenice E 104
11.2.13 La Fenice V 105
11.2.14 Lanzi 105
11.2.15 Mini Pump 105
11.2.16 MiniMed 640G 106
11.2.17 MinIn 106
11.2.18 OmniPod Insulin Pump – New Version 106
11.2.19 Onetouch Ping Verio Insulin Pump with Meter Remote 107
11.2.20 OneTouch with Next Gen Omnipod 107
11.2.21 Patch Pump-1 107
11.2.22 Patch Pump-2 108
11.2.23 Patch Pump-3 108
11.2.24 Spring Insulin Pump 108
11.2.25 Spring Zone Hybrid Patch Pump 109
11.2.26 U-Strip Insulin Patch 109
11.2.27 Exenatide Once Weekly Pen Device 109
11.2.28 Fix-Flex Device 110
11.2.29 G-Pen 110
11.2.30 G-Pen Mini 110
11.2.31 Insulin Guard Self-Injector Safety Needle 111
11.2.32 JuniorSTAR 111
11.2.33 La Fenice Pen 111

11.2.34 Levemir FlexTouch 112
11.2.35 Next Generation Pen Needle II 112
11.2.36 NovoLog FlexTouch 112
12 Global Insulin Delivery Devices Market: Consolidation Landscape 113
12.1 Deals Summary (2004–2013) 113
12.2 Key Deals (2009–2013) 113
12.2.1 LifeScan Acquires Calibra Medical 113
12.2.2 Roche Holding Acquires Medingo from Elron Electronic Industries, 2010 114
12.2.3 Insulet Enters into Co-Development Agreement with Eli Lilly, 2013 114
12.2.4 Tandem Diabetes Enters into Co-Development Agreement with Juvenile Diabetes Research Foundation for Dual-Chamber Infusion Pump, 2013 114
12.2.5 Juvenile Diabetes Research Foundation Extends Co-Development Agreement with Becton, Dickinson, 2012 114
12.2.6 Bioton and SciGen Amend Distribution Agreement with Bayer HealthCare, 2012 115
12.2.7 Insulet Expands Distribution Agreement with Ypsomed Holding, 2012 115
13 Appendix 116
13.1 Definitions 116
13.1.1 Insulin Delivery 116
13.2 Abbreviations 117
13.3 Bibliography 118
13.4 Research Methodology 120
13.4.1 Secondary Research 120
13.4.2 Primary Research 120
13.4.3 Models 121
13.4.4 Forecasts 121
13.4.5 Expert Panel 121
13.5 Contact Us 121
13.6 Disclaimer 121

1.1 List of Tables

Table 1: Insulin Delivery Devices Market, Global, Diabetes National Prevalence (%) and Patient Population (million), 2013 19
Table 2: Insulin Delivery Devices Market, Global, Revenue ($bn), 2005–2012 23
Table 3: Insulin Delivery Devices Market, Global, Revenue ($bn), 2012–2019 24
Table 4: Insulin Delivery Devices Market, Global, Key Company Share by Region (%), 2012 26
Table 5: Insulin Delivery Devices Market, Number of Patients in 10 Largest Markets (Aged 29–79 Years), 2013–2035 32
Table 6: Insulin Delivery Devices Market, Health Expenditure due to Diabetes (20–79 Years) and Diabetes Population, 2013 33
Table 7: Insulin Pens Market, Global, Revenue ($bn), 2005–2012 39
Table 8: Insulin Pens Market, Global, Revenue Forecast ($bn), 2012–2019 40
Table 9: Insulin Pumps Market, Global, Revenue ($m), 2005–2012 41
Table 10: Insulin Pumps Market, Global, Revenue ($m), 2012–2019 42
Table 11: Insulin Syringes Market, Global, Revenue ($m), 2005–2012 43

Table 12: Insulin Syringes Market, Global, Revenue Forecast ($m), 2012–2019 44
Table 13: Traditional Insulin Pump Accessories Market, Global, Revenue ($m), 2005–2012 45
Table 14: Traditional Insulin Pump Accessories Market, Global, Revenue Forecast ($m), 2012–2019 46
Table 15: Insulin Delivery Devices Market, Global, Cross-country Analysis, CAGR (%), 2005–2019 47
Table 16: Insulin Delivery Devices Market, US, Revenue ($bn), Volume (million), 2005–2012 49
Table 17: Insulin Delivery Devices Market, US, Revenue ($bn), Volume (million), 2012–2019 50
Table 18: Insulin Delivery Devices Market, Japan, Revenue ($m), Volume ('000), 2005–2012 52
Table 19: Insulin Delivery Devices Market, Japan, Revenue ($m), Volume ('000), 2012–2019 52
Table 20: Insulin Delivery Devices Market, Germany, Revenue ($m), Volume ('000), 2005–2012 55
Table 21: Insulin Delivery Devices Market, Germany, Revenue ($m), Volume ('000), 2012–2019 55
Table 22: Insulin Delivery Devices Market, France, Revenue ($m), Volume ('000), 2005–2012 58
Table 23: Insulin Delivery Devices Market, France, Revenue ($m), Volume ('000), 2012–2019 58
Table 24: Insulin Delivery Devices Market, UK, Revenue ($m), Volume ('000), 2005–2012 61
Table 25: Insulin Delivery Devices Market, UK, Revenue ($m), Volume ('000), 2012–2019 61

Table 26: Insulin Delivery Devices Market, Spain, Revenue ($m), Volume ('000), 2005–2012 64
Table 27: Insulin Delivery Devices Market, Spain, Revenue ($m), Volume ('000), 2012–2019 64
Table 28: Insulin Delivery Devices Market, Italy, Revenue ($m), Volume ('000), 2005–2012 67
Table 29: Insulin Delivery Devices Market, Italy, Revenue ($m), Volume ('000), 2012–2019 67
Table 30: Insulin Delivery Devices Market, Canada, Revenue ($m), Volume ('000), 2005–2012 70
Table 31: Insulin Delivery Devices Market, Canada, Revenue ($m), Volume ('000), 2012–2019 70
Table 32: Insulin Delivery Devices Market, China, Revenue ($m), Volume ('000), 2005–2012 73
Table 33: Insulin Delivery Devices Market, China, Revenue ($m), Volume ('000), 2012–2019 73
Table 34: Insulin Delivery Devices Market, Australia, Revenue ($m), Volume ('000), 2005–2012 76
Table 35: Insulin Delivery Devices Market, Australia, Revenue ($m), Volume ('000), 2012–2019 76
Table 36: Insulin Delivery Devices Market, India, Revenue ($m), Volume ('000), 2005–2012 79
Table 37: Insulin Delivery Devices Market, India, Revenue ($m), Volume ('000), 2012–2019 79
Table 38: Insulin Delivery Devices Market, Brazil, Revenue ($m), Volume ('000), 2005–2012 82
Table 39: Insulin Delivery Devices Market, Brazil, Revenue ($m), Volume ('000), 2012–2019 82
Table 40: Novo Nordisk, Key Marketed Products, 2013 89
Table 41: Sanofi, Key Marketed Products, 2013 89
Table 42: Eli Lilly, Key Marketed Products, 2013 90
Table 43: Abbott Laboratories, Key Marketed Products, 2013 90
Table 44: Becton, Dickinson and Company, Key Marketed Products, 2013 91

Table 45: Animas, Key Marketed Products, 2013 91
Table 46: F. Hoffmann-La Roche, Key Marketed Products, 2013 92
Table 47: Insulet, Key Marketed Products, 2013 92
Table 48: Asante Solutions, Key Marketed Products, 2013 92
Table 49: Abbott Laboratories, Key Marketed Products, 2013 93
Table 50: Ypsomed Holding AG, Key Marketed Products, 2013 93
Table 51: Owen Mumford, Key Marketed Products, 2014 94
Table 52: Bioject Medical Technologies, Key Marketed Products, 2014 94
Table 53: INJEX - Equidyne Systems, Key Marketed Products, 2014 95
Table 54: Antares Pharma, Key Marketed Products, 2014 95
Table 55: Tandem Diabetes Care, Key Marketed Products, 2014 96
Table 56: Tonghua Dongbao Pharmaceutical, Key Marketed Products, 2014 96
Table 57: Shanghai Fosun Pharmaceutical, Key Marketed Products, 2014 97
Table 58: Insulin Pumps Market, Global, List of Pipeline Products, 2014 99
Table 59: Insulin Pens Market, Global, List of Pipeline Products, 2014 100
Table 60: 5th Generation CGM Sensor With t:slim Insulin Delivery System, Product Status, 2014 100
Table 61: Accu-Chek Insight, Product Status, 2014 100
Table 62: Angel Touch, Product Status, 2014 101
Table 63: Animas Vibe Insulin Pump and CGM System, Product Status, 2014 101
Table 64: Bolus Patch, Product Status, 2014 101
Table 65: Cellnovo Wireless Insulin Pump System, Product Status, 2014 102
Table 66: Freehand Patch Pump, Product Status, 2014 102
Table 67: Insulin Pump, Product Status, 2014 103
Table 68: InsuPatch Device, Product Status, 2014 103
Table 69: Integrated CGM With Next Gen OmniPod System PDM, Product Status, 2014 103
Table 70: Jewel Pump, Product Status, 2014 104
Table 71: La Fenice E, Product Status, 2014 104

Table 72: La Fenice V, Product Status, 2014 105
Table 73: Lanzi, Product Status, 2014 105
Table 74: Mini Pump, Product Status, 2014 105
Table 75: MiniMed 640G, Product Status, 2014 106
Table 76: MinIn, Product Status, 2014 106
Table 77: OmniPod Insulin Pump – New Version, Product Status, 2014 106
Table 78: Onetouch Ping Verio Insulin Pump with Meter Remote, Product Status, 2014 107
Table 79: OneTouch with Next Gen Omnipod, Product Status, 2014 107
Table 80: Patch Pump-1, Product Status, 2014 107
Table 81: Patch Pump-2, Product Status, 2014 108
Table 82: Patch Pump-3, Product Status, 2014 108
Table 83: Spring Insulin Pump, Product Status, 2014 108
Table 84: Spring Zone Hybrid Patch Pump, Product Status, 2014 109
Table 85: U-Strip Insulin Patch, Product Status, 2014 109
Table 86: Exenatide Once Weekly Pen Device, Product Status, 2014 109
Table 87: Fix-Flex Device, Product Status, 2014 110
Table 88: G-Pen, Product Status, 2014 110
Table 89: G-Pen Mini, Product Status, 2014 110
Table 90: Insulin Guard Self-Injector Safety Needle, Product Status, 2014 111
Table 91: JuniorSTAR, Product Status, 2014 111
Table 92: La Fenice Pen, Product Status, 2014 111
Table 93: Levemir FlexTouch, Product Status, 2014 112
Table 94: Next Generation Pen Needle II, Product Status, 2014 112
Table 95: NovoLog FlexTouch, Product Status, 2014 112

1.2 List of Figures
Figure 1: Insulin Delivery Devices Market, Insulin Pump Timeline, 1963–2011 16
Figure 2: Insulin Delivery Devices Market, Device Overview 20
Figure 3: Insulin Delivery Devices Market, Comparison of Insulin Therapy 22
Figure 4: Insulin Delivery Devices Market, Global, Revenue ($bn), 2005–2012 23
Figure 5: Insulin Delivery Devices Market, Global, Revenue ($bn), 2012–2019 24
Figure 6: Insulin Delivery Devices Market, Global, Key Company Share by Region (%), 2012 25
Figure 7: Insulin Delivery Devices Market, Market Trends 27
Figure 8: Insulin Delivery Devices Market, Ongoing/Completed Studies on Artificial Pancreas 28
Figure 9: Insulin Delivery Devices Market, Leading Integrated CGM-Insulin Pump Brands, 2013 29
Figure 10: Insulin Delivery Devices Market, Market Dynamics 31
Figure 11: Insulin Delivery Devices Market, Number of Patients in 10 Largest Markets (Aged 29–79 Years), 2013–2035 31
Figure 12: Insulin Delivery Devices Market, Health Expenditure due to Diabetes (20–79 Years) and Diabetes Population, 2013 33
Figure 13: Insulin Delivery Devices Market, Clinical Studies Indicating Safety and Efficacy of Insulin Pumps 34
Figure 14: Insulin Delivery Devices Market, Annual Cost of Insulin Pumps and Supplies and Annual Cost of Treatment for Serious Complications in Alberta, Canada, 2012 and 2032 35
Figure 15: Insulin Delivery Devices Market, Clinical Studies Indicating Advantages of Insulin Pens Over Syringes 36

Figure 16: Insulin Delivery Devices Market, Patient Compliance Analysis for Insulin Pens and Insulin Syringes 37
Figure 17: Insulin Pens Market, Global, Revenue ($bn), 2005–2012 39
Figure 18: Insulin Pens Market, Global, Revenue Forecast ($bn), 2012–2019 40
Figure 19: Insulin Pumps Market, Global, Revenue ($m), 2005–2012 41
Figure 20: Insulin Pumps Market, Global, Revenue Forecast ($m), 2012–2019 42
Figure 21: Insulin Syringes Market, Global, Revenue ($m), 2005–2012 43
Figure 22: Insulin Syringes Market, Global, Revenue Forecast ($m), 2012–2019 44
Figure 23: Traditional Insulin Pump Accessories Market, Global, Revenue ($m), 2005–2012 45
Figure 24: Traditional Insulin Pump Accessories Market, Global, Revenue Forecast ($m), 2012–2019 46
Figure 25: Insulin Delivery Devices Market, Global, Cross-country Analysis, CAGR (%), 2005–2019 47
Figure 26: Insulin Delivery Devices Market, US, Cross-segment Analysis, CAGR (%), 2005–2019 48
Figure 27: Insulin Delivery Devices Market, US, Revenue ($bn), Volume (million), 2005–2019 49
Figure 28: Insulin Delivery Devices Market, Japan, Cross-segment Analysis, CAGR (%), 2005–2019 51

Figure 29: Insulin Delivery Devices Market, Japan, Revenue and Volume (000s), 2005–2019 51
Figure 30: Insulin Delivery Devices Market, Germany, Cross-segment Analysis, CAGR (%), 2005–2019 53
Figure 31: Insulin Delivery Devices Market, Germany, Revenue ($m), Volume ('000), 2005–2019 54
Figure 32: Insulin Delivery Devices Market, France, Cross-segment Analysis, CAGR (%), 2005–2019 56
Figure 33: Insulin Delivery Devices Market, France, Revenue ($m), Volume ('000), 2005–2019 57
Figure 34: Insulin Delivery Devices Market, UK, Cross-segment Analysis, CAGR (%), 2005–2019 59
Figure 35: Insulin Delivery Devices Market, UK, Revenue ($m), Volume ('000), 2005–2019 60
Figure 36: Insulin Delivery Devices Market, Spain, Cross-segment Analysis, CAGR (%), 2005–2019 62
Figure 37: Insulin Delivery Devices Market, Spain, Revenue ($m), Volume ('000), 2005–2019 63
Figure 38: Insulin Delivery Devices Market, Italy, Cross-segment Analysis, CAGR (%), 2005–2019 65
Figure 39: Insulin Delivery Devices Market, Italy, Revenue ($m), Volume ('000), 2005–2019 66
Figure 40: Insulin Delivery Devices Market, Canada, Cross-segment Analysis, CAGR (%), 2005–2019 68
Figure 41: Insulin Delivery Devices Market, Canada, Revenue ($m), Volume ('000), 2005–2019 69
Figure 42: Insulin Delivery Devices Market, China, Cross-segment Analysis, CAGR (%), 2005–2019 71

Figure 43: Insulin Delivery Devices Market, China, Revenue ($m), Volume ('000), 2005–2019 72
Figure 44: Insulin Delivery Devices Market, Australia, Cross-segment Analysis, CAGR (%), 2005–2019 74
Figure 45: Insulin Delivery Devices Market, Australia, Revenue ($m), Volume ('000), 2005–2019 75
Figure 46: Insulin Delivery Devices Market, India, Cross-segment Analysis, CAGR (%), 2005–2019 77
Figure 47: Insulin Delivery Devices Market, India, Revenue ($m), Volume ('0000), 2005–2019 78
Figure 48: Insulin Delivery Devices Market, Brazil, Cross-segment Analysis, CAGR (%), 2005–2019 80
Figure 49: Insulin Delivery Devices Market, Brazil, Revenue ($m), Volume ('000), 2005–2019 81
Figure 50: Insulin Delivery Devices Market, Comparison of Leading Insulin Pumps by Size and Color Options, 2014 86
Figure 51: Insulin Delivery Devices Market, Comparison of Leading Insulin Pumps by Basal and Bolus Specifications, 2014 87
Figure 52: Insulin Delivery Devices Market, Comparison of Leading Insulin Pumps by Bolus Calculator Options and Operation, 2014 88
Figure 53: Global Insulin Delivery Devices Market, Pipeline Products Summary, 2013 98
Figure 54: Global Insulin Delivery Devices Market, Deals Summary, 2013 113

To order this report: Insulin Delivery Devices Market to 2019 - Simplified Pump Solutions and Low Cost Pens Represent Distinct Regional Growth Drivers
http://www.reportlinker.com/p02077365/Insulin-Delivery-Devices-Market-to-2019---Simplified-Pump-Solutions-and-Low-Cost-Pens-Represent-Distinct-Regional-Growth-Drivers.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_Delivery_Technology

__________________________
Contact Clare: clare@reportlinker.com
US: (339)-368-6001
Intl: +1 339-368-6001

SOURCE Reportlinker



RELATED LINKS
http://www.reportlinker.com

More by this Source

Best of Content We Love 2014 


Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

 

PR Newswire Membership

Fill out a PR Newswire membership form or contact us at (888) 776-0942.

Learn about PR Newswire services

Request more information about PR Newswire products and services or call us at (888) 776-0942.